期刊文献+

Extracellular vesicles:Emerging tools as therapeutic agent carriers 被引量:8

原文传递
导出
摘要 Extracellular vesicles(EVs)are secreted by both eukaryotes and prokaryotes,and are present in all biological fluids of vertebrates,where they transfer DNA,RNA,proteins,lipids,and metabolites from donor to recipient cells in cell-to-cell communication.Some EV components can also indicate the type and biological status of their parent cells and serve as diagnostic targets for liquid biopsy.EVs can also natively carry or be modified to contain therapeutic agents(e.g.,nucleic acids,proteins,polysaccharides,and small molecules)by physical,chemical,or bioengineering strategies.Due to their excellent biocompatibility and stability,EVs are ideal nanocarriers for bioactive ingredients to induce signal transduction,immunoregulation,or other therapeutic effects,which can be targeted to specific cell types.Herein,we review EV classification,intercellular communication,isolation,and characterization strategies as they apply to EV therapeutics.This review focuses on recent advances in EV applications as therapeutic carriers from in vitro research towards in vivo animal models and early clinical applications,using representative examples in the fields of cancer chemotherapeutic drug,cancer vaccine,infectious disease vaccines,regenerative medicine and gene therapy.Finally,we discuss current challenges for EV therapeutics and their future development.
出处 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2022年第10期3822-3842,共21页 药学学报(英文版)
基金 supported by Tulane Weatherhead Endowment Fund (USA)
作者简介 equal contributions:Shan Liu;equal contributions:Xue Wu;Corresponding author:Tony Y.Hu.Tel.:+15049885310,fax:+15049881611.E-mail address:tonyhu@tulane.edu。
  • 相关文献

参考文献4

二级参考文献2

共引文献91

同被引文献24

引证文献8

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部